Home > Compound List > Product Information
Testosterone_Molecular_structure_CAS_58-22-0)
Click picture or here to close

Testosterone

Catalog No. Bio-0678 Name InterBioScreen
CAS Number 58-22-0 Website http://www.ibscreen.com
M. F. C19H28O2 Telephone +7 49652 40091
M. W. 288.42442 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 506

SYNONYMS

IUPAC name
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadec-6-en-5-one
IUPAC Traditional name
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadec-6-en-5-one
Synonyms
Andropatch
Atmos

DATABASE IDS

CAS Number 58-22-0

PROPERTIES

Application(s) Used in the treatment of male hypogonadism (transdermal administration)
Biological Source Constit. of human urine
Mechanism of Action Androgen
Mechanism of Action FSH antagonist.
Mechanism of Action ICSH antagonist
Mechanism of Action The steroid receptor complex is transported to the nucleus where it initiates transcription events and cellular changes related to androgen action
Mechanism of Action High dose: spermatogenesis inhibitor
Mechanism of Action Exogenous administration inhibits endogenous release via feedback inhibition of pituitary ICSH
Mechanism of Action Activity in many tissues appears to depend on reduction to dihydrotestosterone which binds to cytosolic receptor proteins
Mechanism of Action Gonadotropin antagonist

DETAILS

REFERENCES

  • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 52C, (ir)
  • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 2, 800B, (nmr)
  • Lampe, V., Ber., 1918, 51, 1347, (synth)
  • Srinivasan, K.R., J. Pharm. Pharmacol., 1953, 5, 448, (derivs)
  • Jentzsch, K. et al., Sci. Pharm., 1968, 36, 251; CA, 70, 90793h, (isol)
  • Sastry, B.S., Res. Ind., 1970, 15, 258; CA, 75, 75063e, (isol)
  • Kuroyagi, M. et al., Yakugaku Zasshi, 1970, 90, 1467; CA, 74, 61612a, (isol)
  • Dyrssen, D.W. et al., Anal. Chim. Acta, 1972, 60, 139, (detn, B)
  • Roughley, P.J. et al., J.C.S. Perkin 1, 1973, 2379-2388, (biosynth)
  • Karig, F., Dtsch. Apoth. -Ztg., 1975, 115, 325; CA, 83, 65372f, (derivs)
  • Quint, P. et al., Fresenius' Z. Anal. Chem., 1977, 285, 356; 1979, 295, 269, (detn, B)
  • Kashina, C. et al., Heterocycles, 1977, 7, 241, (synth)
  • Wahlstrom, B. et al., Acta Pharmacol. Toxicol., 1978, 43, 86, (metab)
  • Holder, G.M. et al., Xenobiotica, 1978, 8, 761, (metab)
  • Tonnesen, H.H. et al., Acta Chem. Scand., Ser. B, 1982, 36, 475, (cryst struct, bibl)
  • Cheng, K.L. et al., Handbook of Organic Analytical Reagents, CRC Press, Boca Raton, 1982, 511, (use)
  • Ammon, H.P.T. et al., Planta Med., 1991, 57, 1-7, (rev, pharmacol)
  • Jitoe, A. et al., J. Agric. Food Chem., 1992, 40, 1337-1340, (occur)
  • Encyclopedia of Food and Color Additives, (ed. Burdock, G.A.), CRC Press, 1997, 2856-2858
  • Khar, A. et al., FEBS Lett., 1999, 445, 165-168, (antitumour props)